References
- Ereshefsky L, Watanabe M D, Tran-Johnson T K. Clozapine: an atypical antipsychotic agent. Clinical Pharmacology 1989; 8: 691–709
- Gupta S, Rajaprabhakaran R. Paradoxical hypertension associated with clozapine [letter]. American Journal of Psychiatry 1994; 151: 148
- Breier A, Buchanan R W, Waltrip RW, 2nd, Ijsstwak S, Holmes C, Goldstein D S. The effect of clozapine on plasma norepinephnne: relationshp to clinical efficacy. Neuropsychopharmacology 1994; 10: 1–7
- Schulz E, Remschrmdt H, Fleischhaker C. Effect of clozapine on biogenic amines within the scope of drug treatment of schizophrenic psychoses in adolescence. Zeitschrifi für Kinder- und Jugsulpsychiarrie 1994; 22: 285–298
- Svedmyr N. The influence of a tricyclic antidepressant agent (protriptyline) on some of the circulatory effects of nor-adrenaline and adrenaline in man. Life Sciences 1968; 7: 77
- Yeung V TF, Cocluam C S. Endocrine disorders. Textbook of adverse drug reactions. 4th ed, D M Davies. Oxford University Press, Oxford 1991; 344–369
- Donati L, Buhler F R, Berena-Piccoli C, Kusch F, Heinen G. Antihypertensive mechanism of amlodipine in essential hypertension: role of pressor reactivity to norepinephrine and angiotensin II. Clinical Pharmacology and Therapeutics 1992; 52: 50–59
- Olivan J, Moreno R, Hoyos M. Effect of the treatment with amlodipine on left ventricular hypertrophy in hypertensive patients. Anales de Medicina Interna 1996; 13: 531–536